BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12658482)

  • 1. Treatment of human pancreatic cancer in mice with angiogenic inhibitors.
    Prox D; Becker C; Pirie-Shepherd SR; Celik I; Folkman J; Kisker O
    World J Surg; 2003 Apr; 27(4):405-11. PubMed ID: 12658482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis inhibitor TNP-470 reduces human pancreatic cancer growth.
    Hotz HG; Reber HA; Hotz B; Sanghavi PC; Yu T; Foitzik T; Buhr HJ; Hines OJ
    J Gastrointest Surg; 2001; 5(2):131-8. PubMed ID: 11331474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy with tumor-lysate pulsed dendritic cells and antiangiogenic drug TNP-470 for mouse pancreatic cancer.
    Miyazaki J; Tsuzuki Y; Matsuzaki K; Hokari R; Okada Y; Kawaguchi A; Nagao S; Itoh K; Miura S
    Int J Cancer; 2005 Nov; 117(3):499-505. PubMed ID: 15906361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenic and antitumor effects of endostatin on follicular thyroid carcinoma.
    Ye C; Feng C; Wang S; Liu X; Lin Y; Li M
    Endocrinology; 2002 Sep; 143(9):3522-8. PubMed ID: 12193566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibition of growth and metastases of human colon cancer xenograft in nude mice by angiogenesis inhibitor endostatin].
    Zhang GF; Wang YH; Zhang MA; Wang Q; Luo YB; Wang DS; Han CR
    Ai Zheng; 2002 Jan; 21(1):50-3. PubMed ID: 12500397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of the antiangiogenic agent TNP-470 on establishment and growth of hematogenous metastasis of human pancreatic carcinoma in SCID beige mice in vivo.
    Kawarada Y; Ishikura H; Kishimoto T; Saito K; Takahashi T; Kato H; Yoshiki T
    Pancreas; 1997 Oct; 15(3):251-7. PubMed ID: 9336788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiangiogenic treatment with the three thrombospondin-1 type 1 repeats recombinant protein in an orthotopic human pancreatic cancer model.
    Zhang X; Galardi E; Duquette M; Delic M; Lawler J; Parangi S
    Clin Cancer Res; 2005 Mar; 11(6):2337-44. PubMed ID: 15788685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction of midkine gene into human bladder cancer cells enhances their malignant phenotype but increases their sensitivity to antiangiogenic therapy.
    Muramaki M; Miyake H; Hara I; Kamidono S
    Clin Cancer Res; 2003 Nov; 9(14):5152-60. PubMed ID: 14613994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNP-470 fails to block the onset of angiogenesis and early tumor establishment in an intravital minimal disease model.
    Cernaianu G; Frank S; Erbstösser K; Leonhardt S; Cross M; McIvor Z; Scholz G; Dansranjavin T; Celik I; Tannapfel A; Wittekind C; Troebs RB; Rothe K; Bennek J; Hauss J; Witzigmann H
    Int J Colorectal Dis; 2006 Mar; 21(2):143-54. PubMed ID: 15937694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiangiogenic therapy inhibits human neuroblastoma growth.
    Katzenstein HM; Salwen HR; Nguyen NN; Meitar D; Cohn SL
    Med Pediatr Oncol; 2001 Jan; 36(1):190-3. PubMed ID: 11464880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy.
    Hahnfeldt P; Panigrahy D; Folkman J; Hlatky L
    Cancer Res; 1999 Oct; 59(19):4770-5. PubMed ID: 10519381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibition of growth and metastasis of human gastric cancer implanted in nude mice by the angiogenesis inhibitor endostatin].
    Zhang G; Wang Y; Zhang M; Wang Q; Luo Y; Han C; Lu Y; Rao Y
    Zhonghua Wai Ke Za Zhi; 2002 Jan; 40(1):59-61. PubMed ID: 11955383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of endostatin antiangiogenesis gene therapy in vitro and in vivo.
    Jin X; Bookstein R; Wills K; Avanzini J; Tsai V; LaFace D; Terracina G; Shi B; Nielsen LL
    Cancer Gene Ther; 2001 Dec; 8(12):982-9. PubMed ID: 11781661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model.
    Kisker O; Becker CM; Prox D; Fannon M; D'Amato R; Flynn E; Fogler WE; Sim BK; Allred EN; Pirie-Shepherd SR; Folkman J
    Cancer Res; 2001 Oct; 61(20):7669-74. PubMed ID: 11606410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of antiangiogenic therapy with TNP-470 in superficial and invasive bladder cancer models in mice.
    Beecken WD; Fernandez A; Panigrahy D; Achilles EG; Kisker O; Flynn E; Joussen AM; Folkman J; Shing Y
    Urology; 2000 Sep; 56(3):521-6. PubMed ID: 10962337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic inhibition of Sp1 expression in growing tumors by mithramycin a correlates directly with potent antiangiogenic effects on human pancreatic cancer.
    Yuan P; Wang L; Wei D; Zhang J; Jia Z; Li Q; Le X; Wang H; Yao J; Xie K
    Cancer; 2007 Dec; 110(12):2682-90. PubMed ID: 17973266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice.
    Scappaticci FA; Smith R; Pathak A; Schloss D; Lum B; Cao Y; Johnson F; Engleman EG; Nolan GP
    Mol Ther; 2001 Feb; 3(2):186-96. PubMed ID: 11237675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects.
    Abdollahi A; Lipson KE; Sckell A; Zieher H; Klenke F; Poerschke D; Roth A; Han X; Krix M; Bischof M; Hahnfeldt P; Grone HJ; Debus J; Hlatky L; Huber PE
    Cancer Res; 2003 Dec; 63(24):8890-8. PubMed ID: 14695206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The angiogenesis inhibitor tnp-470 effectively inhibits human neuroblastoma xenograft growth, especially in the setting of subclinical disease.
    Shusterman S; Grupp SA; Barr R; Carpentieri D; Zhao H; Maris JM
    Clin Cancer Res; 2001 Apr; 7(4):977-84. PubMed ID: 11309349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endostatin, an antiangiogenic drug, induces tumor stabilization after chemotherapy or anti-CD20 therapy in a NOD/SCID mouse model of human high-grade non-Hodgkin lymphoma.
    Bertolini F; Fusetti L; Mancuso P; Gobbi A; Corsini C; Ferrucci PF; Martinelli G; Pruneri G
    Blood; 2000 Jul; 96(1):282-7. PubMed ID: 10891463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.